Michael J. Zelefsky
Department of Radiation Oncology
Memorial Sloan-Kettering Cancer Center
New York
NY 10065
USA
Name/email consistency: high
- Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer. Zelefsky, M.J., Kollmeier, M., Cox, B., Fidaleo, A., Sperling, D., Pei, X., Carver, B., Coleman, J., Lovelock, M., Hunt, M. Int. J. Radiat. Oncol. Biol. Phys. (2012)
- Comparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer. Zelefsky, M.J., Yamada, Y., Pei, X., Hunt, M., Cohen, G., Zhang, Z., Zaider, M. Urology (2011)
- Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. Zelefsky, M.J., Eastham, J.A., Cronin, A.M., Fuks, Z., Zhang, Z., Yamada, Y., Vickers, A., Scardino, P.T. J. Clin. Oncol. (2010)
- Real-time intraoperative computed tomography assessment of quality of permanent interstitial seed implantation for prostate cancer. Zelefsky, M.J., Worman, M., Cohen, G.N., Pei, X., Kollmeier, M., Yamada, J., Cox, B., Zhang, Z., Bieniek, E., Dauer, L., Zaider, M. Urology (2010)
- Postradiotherapy 2-year prostate-specific antigen nadir as a predictor of long-term prostate cancer mortality. Zelefsky, M.J., Shi, W., Yamada, Y., Kollmeier, M.A., Cox, B., Park, J., Seshan, V.E. Int. J. Radiat. Oncol. Biol. Phys. (2009)
- Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Zelefsky, M.J., Levin, E.J., Hunt, M., Yamada, Y., Shippy, A.M., Jackson, A., Amols, H.I. Int. J. Radiat. Oncol. Biol. Phys. (2008)
- Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer. Zelefsky, M.J., Reuter, V.E., Fuks, Z., Scardino, P., Shippy, A. J. Urol. (2008)
- Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy. Zelefsky, M.J., Nedelka, M.A., Arican, Z.L., Yamada, Y., Cohen, G.N., Shippy, A.M., Park, J.J., Zaider, M. Brachytherapy (2008)
- Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Zelefsky, M.J., Yamada, Y., Fuks, Z., Zhang, Z., Hunt, M., Cahlon, O., Park, J., Shippy, A. Int. J. Radiat. Oncol. Biol. Phys. (2008)
- Long-term outcome following three-dimensional conformal/intensity-modulated external-beam radiotherapy for clinical stage T3 prostate cancer. Zelefsky, M.J., Yamada, Y., Kollmeier, M.A., Shippy, A.M., Nedelka, M.A. Eur. Urol. (2008)
- Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer. Zelefsky, M.J., Kattan, M.W., Fearn, P., Fearon, B.L., Stasi, J.P., Shippy, A.M., Scardino, P.T. Urology (2007)
- Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications. Zelefsky, M.J., Yamada, Y., Cohen, G.N., Sharma, N., Shippy, A.M., Fridman, D., Zaider, M. Radiother. Oncol (2007)
- Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Zelefsky, M.J., Kuban, D.A., Levy, L.B., Potters, L., Beyer, D.C., Blasko, J.C., Moran, B.J., Ciezki, J.P., Zietman, A.L., Pisansky, T.M., Elshaikh, M., Horwitz, E.M. Int. J. Radiat. Oncol. Biol. Phys. (2007)
- Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer. Zelefsky, M.J., Yamada, Y., Cohen, G.N., Shippy, A., Chan, H., Fridman, D., Zaider, M. Int. J. Radiat. Oncol. Biol. Phys. (2007)
- Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. Zelefsky, M.J., Chan, H., Hunt, M., Yamada, Y., Shippy, A.M., Amols, H. J. Urol. (2006)
- Evaluation of postradiotherapy PSA patterns and correlation with 10-year disease free survival outcomes for prostate cancer. Zelefsky, M.J., Ben-Porat, L., Chan, H.M., Fearn, P.A., Venkatraman, E.S. Int. J. Radiat. Oncol. Biol. Phys. (2006)
- PSA bounce versus biochemical failure following prostate brachytherapy. Zelefsky, M.J. Nature Clinical Practice. Urology (2006)
- Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer. Zelefsky, M.J., Ben-Porat, L., Scher, H.I., Chan, H.M., Fearn, P.A., Fuks, Z.Y., Leibel, S.A., Venkatraman, E.S. J. Clin. Oncol. (2005)
- Three-dimensional conformal brachytherapy for prostate cancer. Zelefsky, M.J. Curr. Urol. Rep (2004)
- Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer. Zelefsky, M.J., Moughan, J., Owen, J., Zietman, A.L., Roach, M., Hanks, G.E. Int. J. Radiat. Oncol. Biol. Phys. (2004)
- Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy. Zelefsky, M.J., Yamada, Y., Marion, C., Sim, S., Cohen, G., Ben-Porat, L., Silvern, D., Zaider, M. Int. J. Radiat. Oncol. Biol. Phys. (2003)
- Intensity-modulated radiation therapy for prostate cancer. Zelefsky, M.J., Fuks, Z., Leibel, S.A. Semin. Radiat. Oncol (2002)
- High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Zelefsky, M.J., Fuks, Z., Hunt, M., Yamada, Y., Marion, C., Ling, C.C., Amols, H., Venkatraman, E.S., Leibel, S.A. Int. J. Radiat. Oncol. Biol. Phys. (2002)
- Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer. Zelefsky, M.J., Kelly, W.K., Scher, H.I., Lee, H., Smart, T., Metz, E., Schwartz, L., Fuks, Z., Leibel, S.A. J. Clin. Oncol. (2000)
- Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Zelefsky, M.J., Hollister, T., Raben, A., Matthews, S., Wallner, K.E. Int. J. Radiat. Oncol. Biol. Phys. (2000)
- Postimplantation dosimetric analysis of permanent transperineal prostate implantation: improved dose distributions with an intraoperative computer-optimized conformal planning technique. Zelefsky, M.J., Yamada, Y., Cohen, G., Venkatraman, E.S., Fung, A.Y., Furhang, E., Silvern, D., Zaider, M. Int. J. Radiat. Oncol. Biol. Phys. (2000)
- Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy. Zelefsky, M.J., Lyass, O., Fuks, Z., Wolfe, T., Burman, C., Ling, C.C., Leibel, S.A. J. Clin. Oncol. (1998)
